Related Experiment Video
Updated: Aug 10, 2026
06:32
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
BCG vaccination and pulmonary tuberculosis in Quebec
Canadian Medical Association Journal
|October 9, 1971
Summary
The Bacillus Calmette-Guérin (BCG) vaccination program in Quebec significantly reduced tuberculosis incidence and mortality. Vaccinated individuals showed substantially lower rates of new and severe tuberculosis cases compared to unvaccinated groups.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- The Bacillus Calmette-Guérin (BCG) vaccination was implemented in Quebec in 1949.
- Evaluation of its effectiveness is crucial for public health strategies.
Purpose of the Study:
- To retrospectively evaluate the BCG vaccination program's impact on tuberculosis incidence and mortality in Quebec.
- To assess the program's effectiveness across different age groups (0-14 and 15-29 years).
Main Methods:
- Retrospective analysis of vaccination rates and tuberculosis incidence data from 1956 to 1961.
- Comparison of tuberculosis incidence and mortality rates between vaccinated and unvaccinated populations.
- Stratification of data by age groups: 0-14 years and 15-29 years.
Main Results:
- Primary vaccination rates ranged from 40% to 47.8% of viable births.
- BCG vaccination reduced the incidence of new pulmonary tuberculosis cases by 2.5 to 7 times.
- Severe tuberculosis forms were reduced by 3.7 to 7.6 times in vaccinated individuals.
- Tuberculosis mortality was nearly eliminated in vaccinated groups, while it decreased in unvaccinated groups.
Conclusions:
- The BCG vaccination program in Quebec demonstrated significant effectiveness in reducing tuberculosis incidence and mortality.
- The findings support the continued use and importance of BCG vaccination in public health initiatives.
- The study highlights the protective effect of BCG vaccination across different age demographics.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...